February 25, 2026 – Rockville, Md. – Psomagen is pleased to announce a new partnership with OmicInsight, a provider of AI-powered high-resolution imaging and analysis for spatial biology co-detection of RNA and protein. The company's proprietary SAO imaging technology expands on the capabilites of existing spatial imaging, offering subcellular resolution for large-scale, high-throughput projects.
OmicInsight's EsperTM platform offers:
-
Single-molecule sensitivity, allowing researchers to explore disease mechanisms and behavior at the subcellular level.
-
High-resolution imaging, providing biological insights with accuracy and depth.
-
Customizable analysis pipelines, ensuring users are extracting data relevant to their work.
-
AI-powered workflows, useful for identifying patterns, accelerating decision-making, and making prognostic predictions.
These capabilities have applications in oncology, neurology, and immunology research. OmicInsight data have also been applied to samples in clinical trials, where patient selection processes can be improved with a better understanding of disease and drug biology in tissue context.
At Psomagen, Esper can be accessed as a standalone service, or in conjunction with single-cell sequencing and spatial platforms as a validation tool. This adds to Psomagen's Single-Cell and Spatial Biology Center of Excellence, which includes platforms from 10x Genomics, Bruker/NanoString, Illumina, and PacBio. You can read the Psomagen and OmicInsight partnered press release at the link below:
About Psomagen
Psomagen, Inc., formerly Macrogen U.S.A., is a North American integrative omics solutions and contract laboratory services provider. The company makes cutting-edge technology and data analysis accessible to the academic, pharma, biotech and clinical markets. With both CLIA-certified and CAP-accredited facilities, its team delivers the highest-quality multiomics data using best-in-class DNA, RNA, and protein analysis systems. In conjunction with its bioinformatics capabilities, Psomagen offers a path to insights that is both simple and affordable. Learn more at psomagen.com.
About OmicInsight
OmicInsight Corporation is a company focused on delivering high-sensitivity and high-throughput spatial and multi-omics analysis powered by proprietary artificial intelligence (AI) technology. Headquartered in Santa Clara, CA, the company’s platform is designed to provide unprecedented molecular resolution within biological tissues, enabling deeper insights for drug discovery, precision medicine, and fundamental research. For more information about the Company and its technology platforms, please visit www.omicinsight.com.
